gut microbiome

Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026

CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...

By cGxPwire Editor
April 10, 2026

.Clinical

MaaT Pharma Advances Phase 2 Trial in ICI-Resistant NSCLC

Lyon, France, January 20, 2026 — MaaT Pharma, a late-stage clinical biotechnology company developing microbiome-driven immunotherapies, announced that the...